2025-11-14T12:02:34-06:00 2024-12-31 481032601 ALLEN GIBBS & HOULIK LC 301 N MAIN SUITE 1700 WICHITA KS 672024868 990 2024-01-01 481223461 THE ARTHRITIS RESEARCH CENTER FOUNDATION INC ARTH 3162632125 727 N WACO 200 WICHITA KS 67203 REBECCA SCHUMACHER EXECUTIVE DIRECTOR 3162632125 2025-11-13 1 1 LEANN E STUEVER P01848488 3162677231 2024 2025-03-06 01:10:19Z NATIONAL DATA BANK FOR RHEUMATIC DIS REBECCA SCHUMACHER 727 N WACO 200 WICHITA KS 67203 1852228 0 X N/A X 1999 KS TO INCREASE THE GENERAL BODY OF MEDICAL KNOWLEDGE REGARDING RHEUMATIC DISEASES (ARTHRITIS-RELATED ILLNESSES) BY PERFORMING RESEARCH USING THE DATA BANK AND PUBLISHING THAT RESEARCH IN PEER-REVIEWED MEDICAL JOURNALS. THE CLINICAL RESEARCH IS DESIGNED TO IMPROVE THE TREATMENT AND OUTCOMES OF THESE CONDITIONS. 5 5 11 0 0 0 1263730 1335642 414789 508339 5236 6073 9729 2174 1693484 1852228 0 0 0 0 750013 754551 0 0 0 794543 990334 1544556 1744885 148928 107343 224374 331717 0 0 224374 331717 X TO INCREASE THE GENERAL BODY OF MEDICAL KNOWLEDGE REGARDING RHEUMATIC DISEASES (ARTHRITIS-RELATED ILLNESSES) BY PERFORMING RESEARCH USING THE DATA BANK AND PUBLISHING THAT RESEARCH IN PEER-REVIEWED MEDICAL JOURNALS. THE CLINICAL RESEARCH IS DESIGNED TO IMPROVE THE TREATMENT AND OUTCOMES OF THESE CONDITIONS. 0 0 17500 0 BRISTOL MYERS SQUIBB: TO EXAMINE WHETHER INCREASES IN GC DOSAGE IN RESPONSE TO INCREASE IN DISEASE ACTIVITY RESULT IN WORSE OUTCOMES COMPARED TO CHANGES/ADDITIONS OF OTHER IMMUNOSUPPRESSIVE MEDICATIONS IN SLE PATIENTS AND HEALTH CARE UTILIZATION ASSOCIATED WITH LEVELS OF GC USE. 138158 207372 PSO REGISTRY BMS: IMPROVING THE PUBLIC HEALTH BY ENGAGING IN RESEARCH TO DEVELOP A MORE COMPREHENSIVE UNDERSTANDING OF THE TREATMENT LANDSCAPE AND OUTCOMES OF PATIENTS WITH PSORIASIS. ARCF WILL COLLABORATE AND/OR PARTNER WITH ACADEMIC SITES, INVESTIGATORS, AND PHARMACEUTICAL COMPANIES (COLLECTIVELY, INCLUDING ARCF, "CONSORTIUM OR, INDIVIDUALLY, EACH A "CONSORTIUM MEMBER") TO FURTHER ADVANCE FORWARD PSO. COMPANY WISHES TO SUPPORT FORWARD PSO AS A CONSORTIUM INDUSTRY PARTNER. 32538 199710 JANSSEN RA: TO CHARACTERIZE BASELINE DEMOGRAPHIC DIFFERENCES BETWEEN INDIVIDUALS WITH RA VS INDIVIDUALS WITH IIM AND COMPARE CHANGES IN PATIENT REPORT OUTCOMES (PROS) OVER TIME BETWEEN INDIVIDUALS WITH RA AND IIM. 1437950 103431 ALL OTHER PROGRAM SERVICE INITIATIVES, INCLUDING REGISTRY THAT USES THE INTERNET TO CREATE A COMMUNITY OF ARTHRITIS PATIENTS, WHO WILLINGLY PROVIDE PATIENT INFORMATION TO BE USED FOR DISCOVERY RESEARCH AND THE DEVELOPMENT OF PERSONALIZED MEDICINE FOR PEOPLE WITH ARTHRITIS, TO GATHER DATA TO BE USED FOR ANALYSES OF HEART DISEASE IN RHEUMATOID ARTHRITIS AND USING THE NDB RA PATIENT DATE FROM 1998 THROUGH JUNE 2011 TO DETERMINE THE MOST COMMON TREATMENT PATHWAYS OVER THE PAST DECADE AND CHARACTERIZE THE PATIENTS ON THESE PATHWAYS. 1437950 103431 1626146 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 11 1 0 0 0 0 0 0 0 0 0 0 0 0 X 5 5 0 0 0 0 1 0 0 1 1 0 0 1 0 0 1 1 1 0 KS X X REBECCA SCHUMACHER 3162632125 727 N WACO STE 200 WICHITA KS 67203 DONNA HAWLEY PHD DIRECTOR 1.00 X 0 0 0 THEODORE PINCUS MD DIRECTOR 1.00 X 0 0 0 JAMES R O'DELL MD DIRECTOR 1.00 X 0 0 0 HYON CHOI MD DIRECTOR 1.00 X 0 0 0 KALEB MICHAUD PRESIDENT/DIRECTOR 1.00 X X 0 0 0 REBECCA SCHUMACHER SECRETARY/TREASURER 40.00 X 90417 0 0 90417 0 0 0 0 0 0 0 1335642 1335642 DATA BANK FOR ARTHRITI 900099 508339 508339 508339 6073 6073 CONSULTING FEE 900099 2174 2174 2174 1852228 510513 0 6073 90417 84276 6141 563281 484441 78840 100853 87742 13111 28212 24106 4106 28335 24651 3684 74209 64562 9647 3425 3425 21679 18861 2818 GRANT RELATED EXPENSES 692088 692088 DATA PROCESSING 138992 138992 EQUIPMENT RENT 3014 2622 392 MEMBERSHIPS & SUBSCRIPT 380 380 1744885 1626146 118739 0 167942 292314 4650 184729 149976 56432 34753 224374 331717 0 0 X 224374 331717 224374 331717 224374 331717 107343 0 X 0 1 X 0 0 X 1007684 1240090 666094 1263730 1335642 5513240 1007684 1240090 666094 1263730 1335642 5513240 5513240 4278 38 4150 5236 6073 19775 3810 5777 5700 9729 2174 27190 5560205 2172709 0.99160 0.97980 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 181979 147226 34753 2750 2750 0 34753 1855597 3369 3369 1852228 0 1852228 1748254 3369 3369 1744885 0 1744885 X X X 0 0 0 0 0 0 0 0 0 FORM 990, PART VI, SECTION A, LINE 6 THE ARTHRITIS RESEARCH CENTER FOUNDATION HAS 5 MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B BEFORE FORM 990 IS FILED, IT IS REVIEWED BY REBECCA SCHUMACHER, SECRETARY/EXECUTIVE DIRECTOR. ANY OTHER BOARD COMMITTEE MEMBER MAY REVIEW FORM 990 EITHER BEFORE OR AFTER IT IS FILED. FORM 990, PART VI, SECTION B, LINE 15 PAY FOR HIGHER MANAGEMENT AND DIRECTORS IS DETERMINED BY REVIEW OF RESEARCH ON WHAT THE AVERAGES ARE FOR SIMILAR POSITIONS AND PAY FOR THE DIRECTOR AND EXECUTIVE DIRECTOR ARE APPROVED BY ALL BOARD COMMITTEE MEMBERS. FORM 990, PART VI, SECTION C, LINE 19 THE FORM 990 IS POSTED ON OTHER WEBSITES THAT HAVE A LISTING OF ALL NON-PROFITS. OTHER DOCUMENTS ARE AVAILABLE UPON WRITTEN REQUEST TO THE ORGANIZATION.